Press release
Get your data there without installing new software
New: DssMover Portable makes it easy to send dictations without installing new softwareLondon, 27 April, 2012 – Effective immediately, DssMover Portable, developed by Grundig Business Systems (GBS), is available. For the first time, users can transfer files and send dictations without having to install new software on their computers. They can also use DssMover to quickly and easily configure basic dictation device settings such as author name, transcriber name and e-mail address, and target directory for network transfer. DssMover Portable runs directly on the Digta 7 series dictation devices.
“A Digta 7 equipped with DssMover Portable is great for anyone who wants to remain mobile while they dictate and be able to get their dictations to the secretarial staff quickly – even from constantly changing locations,” says GBS Managing Director Roland Hollstein. There are two ways to send the files: First, dictations can be transferred to a target folder. This option is convenient when the user is working in the same local environment or PC network as the secretarial staff, and both have access to common folders. Second, DssMover Portabe can send dictations by e-mail. The secretarial staff receive the dictations as attachments to an e-mail.
DssMover Portable can be downloaded from the GBS website (www.grundig-gbs.com/en/dssmover) at no cost. Version 1.3 B119 and later versions can be installed on all Digta 7 series devices.
Further information about the Digta 7 dictation device series can be found at www.digta7.com.
About Grundig Business Systems GmbH
With more than four million dictation systems sold and over 50 years of experience, Grundig Business Systems GmbH (GBS) is one of the world’s leading manufacturers of professional dictation systems. It is the only company in the professional dictation industry to develop and produce its cutting-edge products “Made in Germany”. GBS products are distinguished by technical innovation, quality, and top-notch design. Whether for using mobile dictation on the go, with a microphone at the PC, or for making conference recordings, dictation solutions from GBS are on the scene every day, helping attorneys, physicians, companies, and many others to get their work done efficiently and cost-effectively. The independent company, formerly attached to the parent company Grundig, was named one of the top 100 most innovative medium-sized companies. In addition to numerous awards for distinguished product design, GBS received the “IT Innovation Prize 2009” for the world’s first wireless dictation microphone for professional use, the Digta CordEx.
Find out more about GBS on the internet: www.grundig-gbs.com
Grundig Business Systems GmbH
Weiherstr. 10
95448 Bayreuth
Germany
Phone: +49 921 898 0
Fax: +49 921 898 215
Email: info@grundig-gbs.com
Press contact:
Nadine Kiewitt
Phone: +49 921 898 222
Fax: +49 921 898 266
Email: nadine.kiewitt@grundig-gbs.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Get your data there without installing new software here
News-ID: 219467 • Views: …
More Releases from Grundig Business Systems

An office legend turns 60
New: Stenorette in trendy black
Bayreuth, 10th March 2014 – In 2014, Grundig Business Systems GmbH (GBS), one of the global leaders in supplying professional dictation systems, is celebrating the 60th anniversary of the Stenorette. The analogue dictation device was first launched in 1954 and has been sold – through many generations – almost 4.5 million times. “Because of its green color, the first Stenorette got the nickname 'tree frog'. It…
Nuance SpeechMagic 7 now integrates seamlessly with Grundig Business Systems mic …
Users of Nuance speech recognition healthcare solutions can now enjoy the Grundig Business Systems dictation solutions flexibility and performance.
London, 20 December, 2011 – Grundig Business Systems (GBS) has today announced that its dictation products are now compatible with Nuance’s speech recognition solutions. These include SpeechMagic, the healthcare Software Development Kit platform for building a hospital-wide electronic speech infrastructure, and Dragon Medical, the front-end real-time speech recognition solution. Healthcare professionals…
DigtaSoft 4.8 now supports new Digta 7 notification function
Current version of speech processing software allows easier dictation search
London, 13 October, 2011 – Effective immediately, version 4.8 of the DigtaSoft language processing software is available. This version supports additional functions of the Digta 7 mobile dictation device series from Grundig Business Systems (GBS). A new feature is the notification function, also called “Digta Messaging Service”, available with DigtaSoft Pro. This feature allows a notification to be sent to an…
More Releases for GBS
Guillain-Barre Syndrome (GBS) share, Analysis, Growth, Future Outlook | 2025-203 …
Guillain-Barre syndrome is a rare autoimmune condition that affects approximately 100,000 people worldwide each year, with nearly 1 in 78,000 people diagnosed with GBS annually. It is most commonly found in people between the ages of 30 and 50. This disorder occurs when the immune system mistakenly attacks the peripheral nervous system, leading to muscle weakness, numbness, and, in severe cases, paralysis. Although the exact cause of GBS remains unknown,…
Group B Streptococcus GBS Diagnosis Market Industry Trends, Size, and Expansion …
A new Report by CoherentMI Market Reports, titled "Group B Streptococcus GBS Diagnosis Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Group B Streptococcus GBS Diagnosis market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The group B streptococcus (GBS) diagnosis market is estimated to be valued at USD 1.58…
Global Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market to Hit USD …
DataIntelo's latest report reveals that the Group B Streptococcus (GBS) Nucleic Acid Detection Kit Market was valued at USD XX billion in 2023 and is projected to grow at a significant CAGR of XX% by 2032. This substantial growth is primarily attributed to the increased global awareness regarding the serious implications of GBS infections.
As mentioned in the report, raised consciousness about the severity of GBS infections, particularly among pregnant women…
US GBS Market 2023 Share, Size, Key Players, Revenue Analysis | Prudent Markets
The US GBS Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global US GBS market. This report explores all the key factors affecting the growth of the global US GBS market, including…
Guillain-Barre Syndrome (GBS) Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "Guillain-Barre Syndrome (GBS) Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly studies…
B Streptococcus (GBS) Infection Treatment Market to witness remarkable growth By …
"The new report has been added by qyresearch.com to provide detailed insight into the global B Streptococcus (GBS) Infection Treatment market. The study will help to get a better understanding about the B Streptococcus (GBS) Infection Treatment industry competitors, a channel for the distribution, B Streptococcus (GBS) Infection Treatment growth potential, potentially disruptive trends, B Streptococcus (GBS) Infection Treatment industry product innovations, market size value/volume (regional/country level, B Streptococcus (GBS)…